DashboardAll companies
Run this on your own research
Healthcare · Medical Devices

Profusa, Inc.

PFSANASDAQ$0.32−$0.02 (−6.53%)Market closed
USD
Revenue and profit
USD
Margins
% of revenue

Statements

5 periods
Income Statement, USD
ItemFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
Sales00000
Cost of Goods Sold—————
Gross Profit—————
Gross Margin—————
Operating
SG&A24.9M3.0M4.1M5.2M4.8M
R&D2.8M1.6M2.0M4.2M7.7M
Other Expenses—−100.0K−45.0K—−742.0K
Operating Income−27.7M−4.5M−6.1M−9.4M−11.7M
Operating Margin—————
EBITDA−33.6M−4.8M−6.0M−8.7M−10.2M
EBITDA Margin—————
EBIT−33.3M−4.8M−6.0M−13.9M−6.2M
Non-Operating
Other Income—————
Other Expenses2.5M4.4M4.3M6.3M4.1M
Other Income/Expense−3.0M−306.0K72.0K−4.5M5.5M
Net Income
Income Before Tax−35.8M−9.2M−10.3M−20.2M−10.3M
Pre-Tax Margin—————
Income Tax Expense—————
Net Income−35.8M−9.2M−10.3M−20.2M−10.3M
Net Margin—————

Ask an assistant to read this page and explain AlphaLenz.

Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer